4 MRC Cognition and Brain Sciences Unit and University of Cambridge Neurology Unit, Addenbrooke’s Hospital, Cambridge, UK Correspondence to: Professor J R Hodges, MRC Cognition and Brain Sciences Unit ...
OBJECTIVES Repetitive speech phenomena are morphologically heterogeneous iterations of speech which have been described in several neurological disorders such as vascular dementia, progressive ...
Dr Jean-Yves Delattre, Service de Neurologie, Hôpital de la Salpêtrière, 47 Boulevard de l'Hôpital, 75651 Paris Cedex 13, France OBJECTIVES To evaluate the effect of a combination of immunoglobulins ...
OBJECTIVES: To define the clinical, neuropsychological, and radiological features of bilateral parietal lobe atrophy. METHODS: Four patients underwent a comprehensive longitudinal neuropsychological ...
1 Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan 2 Department of Health Science, Nagoya University Graduate School of Medicine 3 Department of Neurology, ...
This study sought to determine the utility of an interlocking finger task in screening for parietal lobe dysfunction. The ability of 69 patients to imitate a standardised set of four interlocking ...
Background Small fibre neuropathy (SFN) affects small myelinated Aδ- and unmyelinated C-fibres and causes neuropathic pain and autonomic symptoms. Earlier Dutch estimates, over a decade old, reported ...
Objectives Chronic inflammatory axonal polyneuropathy (CIAP) is defined on the basis of the clinical, electrophysiological and nerve biopsy findings and therapeutic responses of ‘immunotherapy ...
Biologic therapy and brain atrophy in neuromyelitis optica: a Japanese–German longitudinal MRI study
2 Experimental and Clinical Research Center (ECRC), A Cooperation Between Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Berlin, ...
Role for speech and language professionals in the multidisciplinary approach to functional neurological disorder and related conditions Our ability to communicate with one another is precious. For ...
Background The pathogenic mechanisms underlying autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy (GFAP-A), a central nervous system disorder associated with GFAP autoimmunity, remain ...
Background We report our experience of patients with generalised myasthenia gravis (gMG) treated with efgartigimod, an neonatal Fc receptor antagonist, under the Early Access to Medicine Scheme (EAMS) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results